Paxillin anticorps (Leu25)
Aperçu rapide pour Paxillin anticorps (Leu25) (ABIN2892955)
Antigène
Voir toutes Paxillin (PXN) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Leu25
-
Specificité
- Human Paxillin
-
Purification
- Immunoaffinity purified
-
Immunogène
-
Synthetic peptide around Leu25 of human Paxillin
Type of Immunogen: Synthetic peptide
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.2, 0.05 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
-
-
- Paxillin (PXN)
-
Autre désignation
- PXN / Paxillin
-
Sujet
-
Name/Gene ID: PXN
Synonyms: PXN, Paxillin -
ID gène
- 5829
-
UniProt
- P49023
-
Pathways
- Signalisation MAPK, EGFR Signaling Pathway, Response to Growth Hormone Stimulus, Cell-Cell Junction Organization, Maintenance of Protein Location, CXCR4-mediated Signaling Events, Signaling Events mediated by VEGFR1 and VEGFR2, Signaling of Hepatocyte Growth Factor Receptor, VEGF Signaling
Antigène
-